Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $10.04 in the prior trading day, Drugs Made In America Acquisition Corp (NASDAQ: DMAA) closed at $10.06, up 0.20%. In other words, the price has increased by $0.20 from its previous closing price. On the day, 1.07 million shares were traded. DMAA stock price reached its highest trading level at $10.06 during the session, while it also had its lowest trading level at $10.04.
Ratios:
Our goal is to gain a better understanding of DMAA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.01 and its Current Ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DMAA now has a Market Capitalization of 337182048 and an Enterprise Value of 337843424.
Stock Price History:
Over the past 52 weeks, DMAA has reached a high of $10.27, while it has fallen to a 52-week low of $9.95. The 50-Day Moving Average of the stock is 0.47%, while the 200-Day Moving Average is calculated to be 0.47%.
Shares Statistics:
The stock has traded on average 191.26K shares per day over the past 3-months and 111660 shares per day over the last 10 days, according to various share statistics. A total of 33.52M shares are outstanding, with a floating share count of 5.87M. Insiders hold about 43.88% of the company’s shares, while institutions hold 0.24% stake in the company. Shares short for DMAA as of 1743379200 were 24040 with a Short Ratio of 0.13, compared to 1740700800 on 7580. Therefore, it implies a Short% of Shares Outstanding of 24040 and a Short% of Float of 0.08.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
